Dr. Narendra BS Lead Consultant Endocrinology & Diabetology, Aster Whitefield Hospital GLP-1 drugs are revolutionary, but require nutritional monitoring and strength training to remain safe and effective, per a doctor. While these drugs are being hailed as 'miracle' shots for weight loss, they come with a complex set of side
Novo Nordisk's widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the risk of death from that and major cardiac events by 24%. The trial results are the latest indication that drugs from the GLP-1
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
